Invest Now
Samco Star Rating Ads

ERIS Lifesciences Ltd Price Performance

  • Day's Low
  • ₹1,380.70
  • Day's High
  • ₹1,422.75
₹ 1,389.30
  • 52-w low
  • ₹809.15
  • 52-w high
  • ₹1,593.90
1,389.30
  • Day's open
    ₹1,409.55
  • Previous close
    ₹1,412.15
  • VWAP
    ₹1,403.69
  • Lower price band
    ₹1,129.75
  • Upper price band
    ₹1,694.55

Today's Market Action

The last traded share price of ERIS Lifesciences Ltd was 1,389.30 down by -1.62% on the NSE. Its last traded stock price on BSE was 1,389.35 down by -1.64%. The total volume of shares on NSE and BSE combined was 99,981 shares. Its total combined turnover was Rs 14.03 crores.

ERIS Lifesciences Ltd Medium and Long Term Market Action

ERIS Lifesciences Ltd hit a 52-week high of 1,593.90 on 11-12-2024 and a 52-week low of 809.15 on 13-03-2024. The stock price of ERIS Lifesciences Ltd is up by 3% over the last one month. It is up by 58.78% over the last one year. Don't forget to check the full stock price history in the table below.

ERIS Lifesciences Ltd Fundamentals

  • Market Cap (Cr): 18412

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

ERIS Lifesciences Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

ERIS Lifesciences Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About ERIS Lifesciences Ltd

Data not available.

ERIS Lifesciences Ltd FAQ's

What is Share Price of ERIS Lifesciences Ltd?

What is the Market Cap of ERIS Lifesciences Ltd?

What is PE Ratio of ERIS Lifesciences Ltd?

What is PB Ratio of ERIS Lifesciences Ltd?

What is the CAGR of ERIS Lifesciences Ltd?

How to Buy ERIS Lifesciences Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.

Cons

  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 7.96 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.35. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 164 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 19% of the total company's shareholding which can have a significantly negative impact on stock.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Yellow line
86
0%
0% People are bullish about ERIS Lifesciences Ltd
0%
0 % People are bearish about ERIS Lifesciences Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

ERIS Lifesciences Ltd

1,389.30 -22.85 (-1.62%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91